Dr. Milan Radovich joined Caris Life Sciences in September 2021 and currently serves as Senior Vice President and Chief Scientific Officer. In this role, he leads Caris’ efforts in data-driven scientific advancements in genomic medicine, liquid biopsy, translational research, clinical trials, target discovery and drug development. He also works closely with our numerous academic and biopharma collaborators on joint research in precision medicine.

Before joining Caris, Dr. Radovich was an associate professor at the Indiana University School of Medicine and Vice President for Oncology Genomics at Indiana University Health. At IU, he led a clinical program dedicated to the integration of cutting-edge genomics for the care of advanced cancer patients. His research expertise focused on the use of genomics in translational oncology with a focus on clinical trials, genomically-informed drug combinations, liquid biopsy & MRD, and creating novel bioinformatic pipelines for cancer genome analyses. His work has been published in many high-impact journals and presented at international oncology meetings.